Cargando…
EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities
Gene fusions constitute pivotal driver mutations often encoding aberrant chimeric transcription factors. However, an increasing number of gene fusion events have been shown not to be histotype specific and shared among different tumor types, otherwise completely unrelated clinically or phenotypicall...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584759/ https://www.ncbi.nlm.nih.gov/pubmed/32770123 http://dx.doi.org/10.1038/s41379-020-0646-5 |
_version_ | 1783599654988939264 |
---|---|
author | Argani, Pedram Harvey, Isabel Nielsen, G. Petur Takano, Angela Suurmeijer, Albert J. H. Voltaggio, Lysandra Zhang, Lei Sung, Yun-Shao Stenzinger, Albrecht Mechtersheimer, Gunhild Dickson, Brendan C. Antonescu, Cristina R. |
author_facet | Argani, Pedram Harvey, Isabel Nielsen, G. Petur Takano, Angela Suurmeijer, Albert J. H. Voltaggio, Lysandra Zhang, Lei Sung, Yun-Shao Stenzinger, Albrecht Mechtersheimer, Gunhild Dickson, Brendan C. Antonescu, Cristina R. |
author_sort | Argani, Pedram |
collection | PubMed |
description | Gene fusions constitute pivotal driver mutations often encoding aberrant chimeric transcription factors. However, an increasing number of gene fusion events have been shown not to be histotype specific and shared among different tumor types, otherwise completely unrelated clinically or phenotypically. One such remarkable example of chromosomal translocation promiscuity is represented by fusions between EWSR1 or FUS with genes encoding for CREB-transcription factors family (ATF1, CREB1 and CREM), driving the pathogenesis of various tumor types spanning mesenchymal, neuroectodermal, and epithelial lineages. In this study we investigate a group of 13 previously unclassified malignant epithelioid neoplasms, frequently showing an epithelial immunophenotype and marked predilection for the peritoneal cavity, defined by EWSR1/FUS-CREB fusions. There were 7 females and 6 males, with a mean age of 36 (range 9–63). All except 3 cases occurred intra-abdominally, including one each involving the pleural cavity, upper and lower limb soft tissue. All tumors showed a predominantly epithelioid morphology associated with cystic or microcystic changes and variable lymphoid cuffing either intermixed or at the periphery. All except one case expressed EMA and/or CK, 5 were positive for WT1, while being negative for melanocytic and other mesothelioma markers. Nine cases were confirmed by various RNA sequencing platforms, while in the remaining 4 cases the gene rearrangements were detected by FISH. Eleven cases showed the presence of CREM-related fusions (EWSR1-CREM, 7; FUS-CREM, 4), while the remaining 2 harbored EWSR1-ATF1 fusion. Clinically, 7 patients presented with and/or developed metastases, confirming a malignant biologic potential. Our findings expand the spectrum of tumors associated with CREB-related fusions, defining a novel malignant epithelioid neoplasm with an immunophenotype suggesting epithelial differentiation. This entity appears to display hybrid features between angiomatoid fibrous histiocytoma (cystic growth, lymphoid cuffing) and mesothelioma (peritoneal/pleural involvement, epithelioid phenotype, and cytokeratin and WT1 co-expression). |
format | Online Article Text |
id | pubmed-7584759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-75847592021-02-07 EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities Argani, Pedram Harvey, Isabel Nielsen, G. Petur Takano, Angela Suurmeijer, Albert J. H. Voltaggio, Lysandra Zhang, Lei Sung, Yun-Shao Stenzinger, Albrecht Mechtersheimer, Gunhild Dickson, Brendan C. Antonescu, Cristina R. Mod Pathol Article Gene fusions constitute pivotal driver mutations often encoding aberrant chimeric transcription factors. However, an increasing number of gene fusion events have been shown not to be histotype specific and shared among different tumor types, otherwise completely unrelated clinically or phenotypically. One such remarkable example of chromosomal translocation promiscuity is represented by fusions between EWSR1 or FUS with genes encoding for CREB-transcription factors family (ATF1, CREB1 and CREM), driving the pathogenesis of various tumor types spanning mesenchymal, neuroectodermal, and epithelial lineages. In this study we investigate a group of 13 previously unclassified malignant epithelioid neoplasms, frequently showing an epithelial immunophenotype and marked predilection for the peritoneal cavity, defined by EWSR1/FUS-CREB fusions. There were 7 females and 6 males, with a mean age of 36 (range 9–63). All except 3 cases occurred intra-abdominally, including one each involving the pleural cavity, upper and lower limb soft tissue. All tumors showed a predominantly epithelioid morphology associated with cystic or microcystic changes and variable lymphoid cuffing either intermixed or at the periphery. All except one case expressed EMA and/or CK, 5 were positive for WT1, while being negative for melanocytic and other mesothelioma markers. Nine cases were confirmed by various RNA sequencing platforms, while in the remaining 4 cases the gene rearrangements were detected by FISH. Eleven cases showed the presence of CREM-related fusions (EWSR1-CREM, 7; FUS-CREM, 4), while the remaining 2 harbored EWSR1-ATF1 fusion. Clinically, 7 patients presented with and/or developed metastases, confirming a malignant biologic potential. Our findings expand the spectrum of tumors associated with CREB-related fusions, defining a novel malignant epithelioid neoplasm with an immunophenotype suggesting epithelial differentiation. This entity appears to display hybrid features between angiomatoid fibrous histiocytoma (cystic growth, lymphoid cuffing) and mesothelioma (peritoneal/pleural involvement, epithelioid phenotype, and cytokeratin and WT1 co-expression). 2020-08-07 2020-11 /pmc/articles/PMC7584759/ /pubmed/32770123 http://dx.doi.org/10.1038/s41379-020-0646-5 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Argani, Pedram Harvey, Isabel Nielsen, G. Petur Takano, Angela Suurmeijer, Albert J. H. Voltaggio, Lysandra Zhang, Lei Sung, Yun-Shao Stenzinger, Albrecht Mechtersheimer, Gunhild Dickson, Brendan C. Antonescu, Cristina R. EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities |
title | EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities |
title_full | EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities |
title_fullStr | EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities |
title_full_unstemmed | EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities |
title_short | EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities |
title_sort | ewsr1/fus-creb fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584759/ https://www.ncbi.nlm.nih.gov/pubmed/32770123 http://dx.doi.org/10.1038/s41379-020-0646-5 |
work_keys_str_mv | AT arganipedram ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT harveyisabel ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT nielsengpetur ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT takanoangela ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT suurmeijeralbertjh ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT voltaggiolysandra ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT zhanglei ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT sungyunshao ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT stenzingeralbrecht ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT mechtersheimergunhild ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT dicksonbrendanc ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities AT antonescucristinar ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities |